2023年年报 | 2023年三季报 | 2022年年报 | |
---|---|---|---|
上市前/上市后 | 上市前 | 上市前 | 上市前 |
报表类型 | 合并报表 | 合并报表 | 合并报表 |
流动资产: | |||
货币资金(元) | 52,207,037.34 | 82,417,187.89 | 47,598,382.20 |
应收票据及应收账款(元) | 7,506,806.66 | 15,693,341.25 | 9,516,663.65 |
其中:应收账款(元) | 7,506,806.66 | 15,693,341.25 | 9,516,663.65 |
预付款项(元) | 8,597,223.57 | 3,870,592.00 | 5,654,479.56 |
其他应收款(元) | 2,167,673.51 | 2,404,329.00 | 1,606,124.19 |
存货(元) | 56,769,716.45 | 37,999,761.09 | 43,718,603.61 |
一年内到期的非流动资产(元) | 19,743.07 | 19,461.79 | 46,001.73 |
其他流动资产(元) | 1,919,016.58 | - | - |
流动资产合计(元) | 129,187,217.18 | 142,404,673.02 | 108,140,254.94 |
非流动资产: | |||
长期应收款(元) | 2,254,509.98 | 2,229,509.56 | 2,248,965.34 |
固定资产(元) | 146,748,120.69 | 129,492,625.90 | 64,675,034.63 |
在建工程(元) | 35,100,303.38 | 30,398,052.69 | 102,128,227.28 |
生产性生物资产(元) | 2,410,110.37 | 2,423,594.13 | 2,172,454.56 |
使用权资产(元) | 100,428,054.70 | 101,797,177.47 | 95,108,422.42 |
无形资产(元) | 6,006,284.83 | 4,182,222.57 | 4,515,867.17 |
长期待摊费用(元) | 77,210,558.37 | 67,143,020.46 | 26,521,078.71 |
其他非流动资产(元) | 16,071,660.53 | 16,718,076.86 | 16,885,808.94 |
非流动资产合计(元) | 386,229,602.85 | 354,384,279.64 | 314,255,859.05 |
资产总计(元) | 515,416,820.03 | 496,788,952.66 | 422,396,113.99 |
流动负债: | |||
应付票据及应付账款(元) | 44,613,079.28 | 43,123,610.82 | 29,295,364.15 |
其中:应付账款(元) | 44,613,079.28 | 43,123,610.82 | 29,295,364.15 |
合同负债(元) | 26,737,749.03 | 8,719,530.11 | 10,266,900.93 |
应付职工薪酬(元) | 9,532,678.63 | 6,446,561.00 | 8,379,278.82 |
应交税费(元) | 110,701.49 | 313,640.27 | 261,777.27 |
其他应付款(元) | 1,906,919.49 | 2,593,359.64 | 1,062,886.35 |
一年内到期的非流动负债(元) | 6,544,605.92 | 5,272,927.93 | 7,549,219.90 |
流动负债合计(元) | 89,445,733.84 | 66,469,629.77 | 56,815,427.42 |
非流动负债: | |||
长期借款(元) | 37,966,810.86 | 37,966,810.86 | 25,966,810.86 |
租赁负债(元) | 80,708,460.25 | 83,228,245.12 | 78,528,402.43 |
预计负债(元) | 220,938.88 | 218,916.33 | 211,108.42 |
递延收益(元) | 20,530,692.29 | 20,306,573.21 | 14,704,957.08 |
非流动负债合计(元) | 139,426,902.28 | 141,720,545.52 | 119,411,278.79 |
负债合计(元) | 228,872,636.12 | 208,190,175.29 | 176,226,706.21 |
所有者权益(或股东权益): | |||
实收资本或股本(元) | 139,266,851.00 | 139,266,851.00 | 139,266,851.00 |
资本公积(元) | 27,023,345.98 | 27,023,345.98 | 27,023,345.98 |
盈余公积(元) | 18,335,975.46 | 12,664,956.70 | 12,664,956.70 |
未分配利润(元) | 99,995,337.44 | 107,972,734.19 | 65,251,489.49 |
归属于母公司股东权益合计(元) | 284,621,509.88 | 286,927,887.87 | 244,206,643.17 |
少数股东权益(元) | 1,922,674.03 | 1,670,889.50 | 1,962,764.61 |
股东权益合计(元) | 286,544,183.91 | 288,598,777.37 | 246,169,407.78 |
负债和股东权益合计(元) | 515,416,820.03 | 496,788,952.66 | 422,396,113.99 |
公告日期 | 2024-09-11 | 2024-03-27 | 2024-03-27 |
审计意见(境内) | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 |
原始财报文件下载 | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) |